Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
AMAM Ambrx Biopharma
1.950+0.050+2.63%
Close
01/27 16:00 ET
1.980+0.030+1.54%
Post Mkt Price 01/27 19:56 ET
High
2.030
Open
1.930
Turnover
446.52K
Low
1.910
Pre Close
1.900
Volume
225.84K
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast
News
Comment
Ambrx Biopharma (NYSE:AMAM) Stock Price Up 3.6%
Ambrx Biopharma Inc. (NYSE:AMAM – Get Rating)'s share price rose 3.6% during mid-day trading on Friday . The stock traded as high as $2.02 and last traded at $1.99. Approximately 163,413 shares trade
Ambrx Biopharma (NYSE:AMAM) Vs. Fennec Pharmaceuticals (NASDAQ:FENC) Head-To-Head Survey
Ambrx Biopharma (NYSE:AMAM – Get Rating) and Fennec Pharmaceuticals (NASDAQ:FENC – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two businesse
A Massive Short Squeeze Is Underway: Bed Bath And A Few Favorites Are In Play
Several favorite stocks among retail traders are rocketing higher Wednesday in what could be seen as a short squeeze. Here's a look at the stocks moving and what could be next.
Why Bed Bath & Beyond Shares Are Trading Higher By 17%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers Sotera Health Company (NASDAQ:SHC) shares jumped 92% to $16.59 after the company announced its subsidiaries have reached agreements to settle the Ethylene Oxide cases pending against Sterigeni
Ambrx Biopharma, PaxMedica And 3 More Short Squeeze Stocks That Could Soar This Week
Potential short squeeze plays gained steam in 2021 and have continued to attract attention, with new traders looking for the next huge move. High short interest and a high cost to borrow are among the
EXCLUSIVE: Top 10 Searched Tickers On Benzinga Pro In December 2022: Where Do Tesla, Apple, AMC Rank?
Each trading day features hundreds of headlines and press releases on Benzinga Pro, a source for traders to see the latest news on the overall market and individual tickers. Here is a look at the most
12 Health Care Stocks Moving In Tuesday's Intraday Session
GainersJasper Therapeutics (NASDAQ:JSPR) shares moved upwards by 576.1% to $3.27 during Tuesday's regular session. As of 12:30 EST, this security is trading at a volume of 39.7 million shares, making
Petroleo Brasileiro, Natura & Co, Bit Brother Among Premarket Losers' Pack
Ambrx Biopharma (NYSE:AMAM) and PharmaCyte Biotech (OTCMKTS:PMCBD) Financial Comparison
Ambrx Biopharma (NYSE:AMAM – Get Rating) and PharmaCyte Biotech (OTCMKTS:PMCBD – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies bas
Why Cal-Maine Foods Shares Are Trading Lower; Here Are 24 Stocks Moving Premarket
Gainers Quotient Limited (NASDAQ:QTNT) shares rose 125% to $0.54 in pre-market trading after dropping around 38% on Wednesday. Quotient recently announced the intent to voluntary delist from the Nasda
Company Overview
More
Ambrx Biopharma Inc. operates as a clinical-stage biologics company. It focuses on discovering and developing a novel class of engineered precision biologics using its proprietary expanded genetic code technology platform that allows it to incorporate, in a site-specific manner, synthetic amino acids that do not exist in nature into proteins within living cells. The company was founded in January 2003 and is headquartered in La Jolla, CA.
CEO： Dr. Feng Tian, PhD
Market： NYSE
Listing Date： 06/18/2021
Paper Trade
More
Hot List
TradeSearchNews
SymbolLatest price%Chg
Loading...
Watchlist
No Stock Yet